Wuhan Hiteck Biological Pharma Co (SZSE:300683) Net Interest Income : ¥6.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Wuhan Hiteck Biological Pharma Co's net interest income for the three months ended in Mar. 2025 was ¥1.2 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥6.1 Mil.

Wuhan Hiteck Biological Pharma Co Net Interest Income Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Net Interest Income Chart

Wuhan Hiteck Biological Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Interest Income

Get a 7-Day Free Trial

19.83

12.54

11.25

7.14

5.13

Wuhan Hiteck Biological Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Interest Income	Get a 7-Day Free Trial															0.24	1.53	1.37	2.00	1.18

Wuhan Hiteck Biological Pharma Co Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.1 Mil.

Wuhan Hiteck Biological Pharma Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hiteck Biological Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Net Interest Income

Traded in Other Exchanges

N/A

Address

Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056

Website

http://www.hiteck.com.cn

Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Executives

Yan Jie	Director
Li Sheng Qiang	Executives

Wuhan Hiteck Biological Pharma Co Headlines

No Headlines